[Present and future in development of new anti-influenza drugs].

Akira Watanabe

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Against pandemic influenza A (H1N1) 2009, anti-influenza drugs were useful to save the disease aggravation and reduce the mortality. In addition to the existing anti-influenza drugs, novel drugs, including neuraminidase inhibitors (peramivir and laninamivir) and RNA polymerase inhibitors (favipiravir), also have clinical potentials to suppress pandemic influenza A (H1N1) 2009 virus as well as seasonal influenza virus.

    Original languageEnglish
    Pages (from-to)1685-1689
    Number of pages5
    JournalNippon rinsho. Japanese journal of clinical medicine
    Volume68
    Issue number9
    Publication statusPublished - 2010 Sep

    ASJC Scopus subject areas

    • Medicine(all)

    Fingerprint

    Dive into the research topics of '[Present and future in development of new anti-influenza drugs].'. Together they form a unique fingerprint.

    Cite this